Exiqon A/ Company Profile

14:44 EDT 20th June 2018 | BioPortfolio

Exiqon is the global provider of Locked Nucleic Acid (LNA™) and a leading supplier of high-value gene expression analysis products and web-based software tools to help scientists achieve rapid and reliable results.Our product portfolio includes our miRCURY™ product line for microRNA research as well as custom LNA™ oligonucleotides.


Bygstubben 9


Phone: 45 45 66 08 88
Fax: 45 45 66 18 88

News Articles [1 Associated News Articles listed on BioPortfolio]

Exiqon AS Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09032018] Prices from USD $250

SummaryExiqon A/S Exiqon, a subsidiary of Qiagen NV is a medical device company that develops, manufactures and markets molecular diagnostic test products. The company's product categories include mic...

Drugs and Medications [0 Results]


PubMed Articles [4 Associated PubMed Articles listed on BioPortfolio]

Profiling of 179 miRNA Expression in Blood Plasma of Lung Cancer Patients and Cancer-Free Individuals.

Lung cancer is one of major cancers, and survival of lung cancer patients is dictated by the timely detection and diagnosis. Cell-free circulating miRNAs were proposed as candidate biomarkers for lung...

Serum miRNA levels are related to glucose homeostasis and islet autoantibodies in children with high risk for type 1 diabetes.

Micro RNAs (miRNAs) are promising disease biomarkers due to their high stability. Their expression in serum is altered in type 1 diabetes, but whether deviations exist in individuals with high risk fo...

Identification of four plasma microRNAs as potential biomarkers in the diagnosis of male lung squamous cell carcinoma patients in China.

Dysregulated microRNAs (miRNAs) in the plasma of patients with lung squamous cell carcinoma (LSCC) might serve as biomarkers for LSCC diagnosis. The expression of miRNAs was performed using quantitati...

Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis.

The differential expression of microRNAs (miRNAs) in plasma of pancreatic cancer (PC) patients may act as a diagnostic biomarker. A four-stage study was performed to identify plasma miRNAs with potent...

Clinical Trials [0 Results]


Companies [3 Associated Companies listed on BioPortfolio]


Exiqon operates in two business segments sharing one vision: the idea of taking science to patients through personalized medicine; one focus: the promise of miRNA as biological markers; and one techno...

Exiqon A/S

Exiqon A/S focused on the development of novel DNA and immunodiagnostic products against common genetic diseases, in particular, cardiovascular, diabetic and other chronic and degenerative diseases.

Exiqon A/

Exiqon is the global provider of Locked Nucleic Acid (LNA™) and a leading supplier of high-value gene expression analysis products and web-based software tools to help scientists achieve rapid and r...

More Information about "Exiqon A/" on BioPortfolio

We have published hundreds of Exiqon A/ news stories on BioPortfolio along with dozens of Exiqon A/ Clinical Trials and PubMed Articles about Exiqon A/ for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Exiqon A/ Companies in our database. You can also find out about relevant Exiqon A/ Drugs and Medications on this site too.

Quick Search


Relevant Topic

Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Corporate Database Quicklinks

Searches Linking to this Company Record